Biogen
BIIB
BIIB
946 hedge funds and large institutions have $27.8B invested in Biogen in 2024 Q1 according to their latest regulatory filings, with 102 funds opening new positions, 300 increasing their positions, 353 reducing their positions, and 144 closing their positions.
New
Increased
Maintained
Reduced
Closed
less call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
17% less capital invested
Capital invested by funds: $33.5B → $27.8B (-$5.74B)
20% less funds holding in top 10
Funds holding in top 10: 10 → 8 (-2)
29% less first-time investments, than exits
New positions opened: 102 | Existing positions closed: 144
Holders
946
Holding in Top 10
8
Calls
$301M
Puts
$303M
Top Buyers
| 1 | +$466M | |
| 2 | +$129M | |
| 3 | +$123M | |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$86.3M |
| 5 |
VanEck Associates
New York
|
+$68.2M |
Top Sellers
| 1 | -$314M | |
| 2 | -$139M | |
| 3 | -$93.5M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$82.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$82M |